share_log

Tenaya Therapeutics shares are trading higher after HC Wainwright & Co. initiated coverage on the stock with a Buy rating and a $25 price target.

Benzinga ·  Jun 15, 2022 23:05
Tenaya Therapeutics shares are trading higher after HC Wainwright & Co. initiated coverage on the stock with a Buy rating and a $25 price target.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment